Kangmei Pharmaceutical Co.,Ltd. Posted 125.1 Million Yuan Net Loss in First Half of 2023

Kangmei Pharmaceutical Co.,Ltd. (康美药业股份有限公司) (600518.SH) reported a net loss of 125.1 million yuan in the first half of 2023, narrowing 36% year-on-year.

Meanwhile, the company posted 2.4 billion yuan in revenue, up 33.6% year-on-year.

At the end of the reporting period, it had 14.6 billion yuan in total assets and 7.7 billion yuan in total liabilities, with a liability-to-asset ratio of 53%.